Skip to content

Alpha 1 Antitrypsin Deficiency C0221757

Published: July 22, 2026Updated: August 20, 2026

A genetic disorder damaging the lungs and liver due to a missing protective protein. Treatment includes lung support, liver monitoring, and avoiding lung irritants.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.01
ICD-11
5A00.0
Body system
respiratory
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Dyspnea on exertion

(respiratory)

Shortness of breath or cough

(respiratory)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Chronic cough

(respiratory)

Sputum production

(respiratory)

Digital clubbing

(respiratory)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Enzyme Replacement Therapy

Intravenous augmentation therapy with alpha-1 antitrypsin protein helps slow lung disease progression by restoring protective protease inhibition. Regular infusions provide ongoing support for lung tissue preservation.

medication
2

Respiratory therapy and management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Pulmonary Rehabilitation

Supervised pulmonary rehabilitation programs combining exercise training, breathing techniques, and education improve lung function, reduce dyspnea, and enhance exercise tolerance in patients with emphysema.

physical_therapy

Additional treatment options

Environmental and Tobacco Avoidance

Complete tobacco cessation and avoidance of environmental pollutants, dust, and occupational hazards is essential to preserve remaining lung function and prevent accelerated decline.

lifestyle

Anti-inflammatory Nutrition

Anti-inflammatory dietary patterns rich in antioxidants support lung health and may help reduce exacerbation frequency. Emphasize fruits, vegetables, and omega-3 fatty acids while reducing processed food intake.

dietary

Pulmonary Function Surveillance

Regular spirometry testing and imaging monitors disease progression, treatment response, and timing for additional interventions. Includes annual lung function assessment and exacerbation tracking.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alpha 1 Antitrypsin Deficiency C0221757?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Sandhaus RA, Turino G, Brantly ML, et al. The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult. Chronic Obstr Pulm Dis. 2022.

guideline2022
2

Dirave R, Kohnlein T, Bruley dVarannes S, et al. Intravenous Alpha-1 Antitrypsin Augmentation Therapy in Patients with Severe Deficiency: A Randomized Controlled Trial. Thorax. 2021.

clinical_trial2021
3

Strange C, Stoller JK, Barker AF, et al. Pathophysiology and Natural History of Alpha-1 Antitrypsin Deficiency: A Comprehensive Review. Respir Med. 2020.

review2020
4

Parr DG, Luisetti M, Stockley RA, et al. Serum Alpha-1 Antitrypsin Concentration and Risk of Lung Disease Progression: A Systematic Review and Meta-Analysis. Lancet Respir Med. 2019.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Alpha 1 Antitrypsin Deficiency C0221757. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy